Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
is an advanced-generation cephalosporin antibiotic
PubMed Central PMCID: PMC4315073
CAS Number: 1373423-53-0
Bcl-xL and Mcl-1 cooperate to protect cancer cells against apoptosis and their concomitant inhibition leads to massive apoptosis even in the absence of chemotherapy
Chemical Name: N'-(2-{8-[(4-bromophenyl)sulfanyl]-2
AN-2690 Size:Solid 2 mg is an advanced-generation cephalosporin antibioticTavaborole, also known as AN 2690 (trade name Kerydin) is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed. Tavaborole began its Phase 3 trials in December 2010 and was approved in July 2014. Tavaborole inhibits an essential fungal enzyme, Leucyl tRNA synthetase, or LeuRS, required for protein synthesis. The inhibition of protein synthesis leads to termination of cell growth and cell